1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GENMAB - ADR
26.22 0.36 (1.39%)
399.4K
XNAS Volume

XNAS 25 Jun, 2026 10:36 AM (EDT)

Watchlist

Portfolio

Alert

Genmab (ADR) - GMAB - stock price prediction, stock price target, analyst ratings from 11 analysts

Genmab (ADR) has a share price target of US$ 37, revenue growth forecast of 14.7%, and profit growth estimate of -23.9% for FY26, based on top 11 analyst calls.